Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 75.61 is 175% above its 4-year average of 27.51, near the high end of its 4-year range (0.98–75.61).
As of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
75.61
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
40.77
PEG RATIO AVG 5Y
27.51
PEG RATIO AVG 10Y
12.59
PEG RATIO AVG 15Y
12.86
PEG RATIO AVG 20Y
1.83
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+85.43%
CURRENT VS 5Y AVG
+174.85%
CURRENT VS 10Y AVG
+500.49%
CURRENT VS 15Y AVG
+488.07%
CURRENT VS 20Y AVG
+4031.69%
SECTOR MEDIAN · HEALTHCARE
1.86
median of 49 covered companies
CURRENT VS SECTOR MEDIAN
+3965.05%
vs the sector median at left
Market Cap
$25.15B
PEG Ratio
1.43
TTM Avg
4.21
3Y Avg
4.21
5Y Avg
2.20
Market Cap
$23.10B
PEG Ratio
33.99
TTM Avg
33.99
3Y Avg
32.78
5Y Avg
16.88
Market Cap
$22.43B
PEG Ratio
1.16
TTM Avg
0.84
3Y Avg
0.59
5Y Avg
0.59
Market Cap
$26.82B
PEG Ratio
8.96
TTM Avg
5.67
3Y Avg
4.53
5Y Avg
3.90
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $24.42B | 75.61 | N/A | 40.77 | 27.51 |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 1.28 | 0.79 | 0.79 | 0.47 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 1.43 | 4.21 | 4.21 | 2.20 |
| Incyte Corporation (INCY)vs › | $23.51B | 0.78 | 0.00 | 0.16 | 0.24 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 33.99 | 33.99 | 32.78 | 16.88 |
| BioNTech SE (BNTX)vs › | $22.59B | N/A | 0.23 | 0.12 | 0.12 |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 1.16 | 0.84 | 0.59 | 0.59 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 8.96 | 5.67 | 4.53 | 3.90 |
| Moderna, Inc. (MRNA)vs › | $21.45B | N/A | 0.18 | 0.14 | 0.14 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 4.14 | 2.27 | 2.27 | 1.52 |
PEG Ratio
75.61
P/E Ratio
47.6
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 75.61 |
| 2022-12-31 | 5.94 |
| 2021-12-31 | 0.98 |
| 2019-12-31 | 1.96 |
| 2018-12-31 | 0.01 |
| 2016-12-31 | 1.56 |
| 2015-12-31 | 2.08 |
| 2013-12-31 | 49.81 |
| 2012-12-31 | 1.65 |
| 2011-12-31 | 1.00 |
| 2010-12-31 | 0.83 |
| 2009-12-31 | 4.98 |
| 2008-12-31 | 0.52 |
| 2007-12-31 | 1.25 |
| 2006-12-31 | 1.03 |
| 2004-12-31 | 0.72 |
| 2003-12-31 | 1.04 |
| 2002-12-31 | 0.68 |
| 2000-12-31 | 4.83 |
| 1999-12-31 | 0.43 |
| 1996-12-31 | 1.27 |
